Particle.news

CVS Health to Split Retail Pharmacies From Insurance and Drug-Benefit Units

The company says the move will address regulatory scrutiny of vertical integration by creating two focused, publicly traded businesses by the first half of 2028.

Overview

  • CVS announced on Wednesday that it will break into two companies, separating its roughly 9,000 retail pharmacies from its insurance and pharmacy-benefit management operations.
  • One of the two firms will keep the CVS Health name and be led by CEO David Joyner while the standalone pharmacy business will operate as a separate public company.
  • Executives and analysts framed the decision as a response to growing regulatory scrutiny of vertically integrated healthcare firms and to persistent pressures on retail pharmacy from rivals like Amazon and rising prescription delivery.
  • The split will leave both firms publicly traded and give current shareholders stakes in each, with completion targeted in the first half of 2028.
  • CVS built the integrated model through major acquisitions such as Caremark and Aetna and in 2025 posted large, uneven segment revenue totals that highlight why the company says focused businesses could improve competitiveness and clarity for investors.